A detailed history of Paradigm Biocapital Advisors LP transactions in Merus N.V. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 2,454,917 shares of MRUS stock, worth $122 Million. This represents 4.42% of its overall portfolio holdings.

Number of Shares
2,454,917
Previous 2,019,814 21.54%
Holding current value
$122 Million
Previous $120 Million 2.62%
% of portfolio
4.42%
Previous 4.84%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $20.5 Million - $25.6 Million
435,103 Added 21.54%
2,454,917 $123 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $80.4 Million - $122 Million
2,019,814 New
2,019,814 $120 Million
Q3 2022

Nov 14, 2022

BUY
$18.64 - $28.93 $2.09 Million - $3.24 Million
111,970 Added 24.76%
564,214 $11.3 Million
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $2.83 Million - $5.92 Million
202,506 Added 81.09%
452,244 $10.2 Million
Q1 2022

May 16, 2022

BUY
$23.58 - $30.91 $5.89 Million - $7.72 Million
249,738 New
249,738 $6.6 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.